Interesting recent posts. When we talk of gene therapy as a impending threat, how does cost of gene therapy compare to that of NZ2591? Is advantage of gene therapy that it is a cure rather than a treatment? I guess this where the importance of HIE to longer-term sales revenue is greater than most other indications where genetic "fault" is the cause. I wonder if the market is across that yet? The world of science is certainly very dynamic.
Interesting recent posts. When we talk of gene therapy as a...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.20 |
Change
0.570(3.43%) |
Mkt cap ! $2.167B | |||
| Open | High | Low | Value | Volume |
| $16.80 | $17.34 | $16.63 | $4.016M | 236.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1 | $17.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.21 | 24 | 2 |
View Market Depth
| Last trade - 12.54pm 31/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |